AI for C. Difficile Identification
Findings on the Biotia Microbial Surveillance System
Nearly one half million Americans contract Clostridia difficile (C. difficile) infections each year making it the most common hospital acquired infection (HAI)
Strategies to reduce infections include improving infection control and healthcare facility cleaning/disinfection, especially to prevent further contamination within the hospital
The current gold-standard approaches for pathogen identification via culturing or PCR-based assays have critical limitations, impacting timely treatment and infection control measures
Biotia Leverages Genomics and AI to Provide Diagnostic Insights
Biotia is a next-generation sequencing (NGS) technology platform utilizing a curated database and artificial intelligence (AI) software to create an active surveillance system to detect both high-risk environments and high-risk patients.